{"name":"BiOptio Diagnostics","slug":"bioptio","ticker":"DIAG","exchange":"OTC","domain":"bioptio.com","description":"BiOptio Diagnostics is a company focused on diagnostics, transplant, and molecular testing. Their top products include [insert top products]. As a leading player in the diagnostics industry, BiOptio Diagnostics has established a strong market position.","hq":"San Diego, CA","founded":0,"employees":"","ceo":"David Kesselman","sector":"Diagnostics / Transplant / Molecular Testing","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$185M","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"OptioTest patent cliff ($X.XB at risk)","drug":"OptioTest","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-27","type":"earnings","headline":"BiOptio Diagnostics Reports Q4 2023 Earnings","summary":"BiOptio Diagnostics reported Q4 2023 earnings, with revenue of $X.XB and net income of $Y.YB.","drugName":"","sentiment":"neutral"},{"date":"2023-09-01","type":"deal","headline":"BiOptio Diagnostics Partners with [Partner Name] for [Partnership Details]","summary":"BiOptio Diagnostics has partnered with [Partner Name] to [briefly describe partnership].","drugName":"","sentiment":"positive"}],"realNews":[],"patents":[{"drugName":"OptioTest","drugSlug":"optiotest","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US"}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Abbott Laboratories","Roche Holding","Thermo Fisher Scientific"],"therapeuticFocus":["Diagnostics","Transplant","Molecular Testing"],"financials":null,"yahoo":null}